About: Guidance for pediatric hematology-oncology (PHO) and hematopoietic stem cell transplant services during COVID-19 pandemic: A consensus statement by PHO chapter of Indian academy of pediatrics

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Guidance for pediatric hematology-oncology (PHO) and hematopoietic stem cell transplant services during COVID-19 pandemic: A consensus statement by PHO chapter of Indian academy of pediatrics Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Guidance for pediatric hematology-oncology (PHO) and hematopoietic stem cell transplant services during COVID-19 pandemic: A consensus statement by PHO chapter of Indian academy of pediatrics
Creator	Radhakrishnan, Nita Banavali, Shripad Bansal, Maya Bhat, Sunil Bhattacharya, Arpita Chinnaswamy, Girish Kanwar, Vikramjit Katewa, Satyendra Kharya, Gaurav Manglani, Mamta Mehdi, Intezar Narula, Gaurav Prakash, Satya Prasad, Amita Raj, Revathi Sharma, Ratna Sirisharani, Deepak Trehan,
source	Elsevier; PMC
abstract	Abstract With the recent Pandemic of Covid-19 affecting more than 180 countries across the globe, services to children with blood disorders and cancers are likely to be affected. Children, in general, are at lesser risk of developing severe diseases and mortality, and mostly recover from it; fortunately, till date, very few cases have been reported in children with cancers. However, since this is an unprecedented pandemic, there is a felt need for guidance on the challenges faced in providing care to children with cancers and various blood disorders including those requiring Hematopoietic Stem Cell Transplantation (HSCT). This document will provide guidance on how to maintain continuity of care for children with blood disorders & cancers during the COVID-19 pandemic while exercising all precautions to reduce the risk of Covid-19 in this vulnerable group and if infected, what optimum care should be provided to these children.
has issue date	2020-07-28(xsd:dateTime)
bibo:doi	10.1016/j.phoj.2020.07.004
has license	els-covid
sha1sum (hex)	6f0a191acf224af272d4ab7c5ab13b9d1f3003b9
schema:url	https://doi.org/10.1016/j.phoj.2020.07.004
resource representing a document's title	Guidance for pediatric hematology-oncology (PHO) and hematopoietic stem cell transplant services during COVID-19 pandemic: A consensus statement by PHO chapter of Indian academy of pediatrics
has PubMed Central identifier	PMC7386853
resource representing a document's body	covid:6f0a191acf224af272d4ab7c5ab13b9d1f3003b9#body_text
is schema:about of	named entity 'Table' named entity 'Pandemic' named entity 'services' named entity 'PHO' named entity 'Running' named entity 'Text' named entity 'Indian Academy of Pediatrics' named entity 'high-risk' named entity 'Pediatric' named entity 'breathing difficulty' named entity 'oncology' named entity 'COVID-19' named entity 'cough' named entity 'neuroblastoma' named entity 'health care' named entity 'COVID-19' named entity 'complete remission' named entity 'Rituximab' named entity 'COVID-19 pandemic' named entity 'thalassemia' named entity 'fever' named entity 'COVID-19' named entity 'blood disorders' named entity 'chemotherapy' named entity 'respiratory symptoms' named entity 'risk of Covid-19' named entity 'Covid' named entity 'hospital settings' named entity 'hematological' named entity 'COVID' named entity 'face mask' named entity 'aplastic anemia' named entity 'autologous' named entity 'DKMS' named entity 'New York' named entity 'immunotherapies' named entity 'triage' named entity 'prophylactic' named entity 'conventional treatment' named entity 'remission' named entity 'blood disorders' named entity 'SIOP' named entity 'neuroblastoma' named entity '1, 2' named entity 'maintenance chemotherapy' named entity 'HSCT' named entity 'HLA' named entity 'COVID' named entity 'chemotherapy' named entity 'multidisciplinary team' named entity 'care for children' named entity 'quarantine zone' named entity 'COVID' named entity 'supportive care' named entity '250,000' named entity '5.7%' named entity 'oncology' named entity 'blood disorders' named entity 'lymphomas' named entity 'Italy' named entity 'infectious disease' named entity 'Wuhan' named entity 'immunosuppressive' named entity 'tumor' named entity 'COVID' named entity 'COVID-19' named entity 'blood component'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software